SOOBF yields 11.77% · JNJ yields 2.13%● Live data
📍 SOOBF pulled ahead of the other in Year 1
Combined, SOOBF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SOOBF + JNJ for your $10,000?
Sapporo Holdings Limited engages in alcoholic beverages, foods and soft drinks, restaurants, and real estate businesses in Japan and internationally. It operates through Alcoholic Beverages, Food & Soft Drinks, and Real Estate segments. The company manufactures and sells beer, wine, other alcoholic beverages, foods, sundries, shochu, and other food products; operates restaurants and factories; and offers soft drinks, soups, and soybeans and chilled products, as well as provides consigned freight forwarding, cargo handling, warehousing, packaging, and distribution services. It also manufactures, markets, and sells beverages and food products; operates vending machines and café chain; serves tea; and manufactures and sells ice cream, miso, instant miso soup, and freeze-dried products. In addition, the company engages in the development, leasing, rental, and sale of real estate properties. As of December 31, 2021, it operated 162 restaurant outlets. The company sells its beer products under the Black label, Yebisu, GOLD STAR, SAPPORO PREMIUM BEER, ANCHOR, and Mugi to Hop brand names. Sapporo Holdings Limited was founded in 1876 and is headquartered in Tokyo, Japan.
Full SOOBF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.